204 related articles for article (PubMed ID: 16919470)
1. BLyS receptor signatures resolve homeostatically independent compartments among naïve and antigen-experienced B cells.
Treml LS; Crowley JE; Cancro MP
Semin Immunol; 2006 Oct; 18(5):297-304. PubMed ID: 16919470
[TBL] [Abstract][Full Text] [Related]
2. BLyS and B cell homeostasis.
Woodland RT; Schmidt MR; Thompson CB
Semin Immunol; 2006 Oct; 18(5):318-26. PubMed ID: 16931037
[TBL] [Abstract][Full Text] [Related]
3. Travelling with the BAFF/BLyS family: are we there yet?
Mackay F; Cancro MP
Semin Immunol; 2006 Oct; 18(5):261-2. PubMed ID: 16905331
[No Abstract] [Full Text] [Related]
4. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
Katsenelson N; Kanswal S; Puig M; Mostowski H; Verthelyi D; Akkoyunlu M
Eur J Immunol; 2007 Jul; 37(7):1785-95. PubMed ID: 17557373
[TBL] [Abstract][Full Text] [Related]
5. BAFF, APRIL and human B cell disorders.
Tangye SG; Bryant VL; Cuss AK; Good KL
Semin Immunol; 2006 Oct; 18(5):305-17. PubMed ID: 16916610
[TBL] [Abstract][Full Text] [Related]
6. BAFF, APRIL and their receptors: structure, function and signaling.
Bossen C; Schneider P
Semin Immunol; 2006 Oct; 18(5):263-75. PubMed ID: 16914324
[TBL] [Abstract][Full Text] [Related]
7. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
[TBL] [Abstract][Full Text] [Related]
8. BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors.
Zhang X; Park CS; Yoon SO; Li L; Hsu YM; Ambrose C; Choi YS
Int Immunol; 2005 Jun; 17(6):779-88. PubMed ID: 15908449
[TBL] [Abstract][Full Text] [Related]
9. The role of the BAFF/APRIL system on T cell function.
Mackay F; Leung H
Semin Immunol; 2006 Oct; 18(5):284-9. PubMed ID: 16931039
[TBL] [Abstract][Full Text] [Related]
10. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.
Alexaki VI; Notas G; Pelekanou V; Kampa M; Valkanou M; Theodoropoulos P; Stathopoulos EN; Tsapis A; Castanas E
J Immunol; 2009 Nov; 183(9):5948-56. PubMed ID: 19828625
[TBL] [Abstract][Full Text] [Related]
11. Activation and accumulation of B cells in TACI-deficient mice.
Yan M; Wang H; Chan B; Roose-Girma M; Erickson S; Baker T; Tumas D; Grewal IS; Dixit VM
Nat Immunol; 2001 Jul; 2(7):638-43. PubMed ID: 11429549
[TBL] [Abstract][Full Text] [Related]
12. Identification of proteoglycans as the APRIL-specific binding partners.
Ingold K; Zumsteg A; Tardivel A; Huard B; Steiner QG; Cachero TG; Qiang F; Gorelik L; Kalled SL; Acha-Orbea H; Rennert PD; Tschopp J; Schneider P
J Exp Med; 2005 May; 201(9):1375-83. PubMed ID: 15851487
[TBL] [Abstract][Full Text] [Related]
13. TACI attenuates antibody production costimulated by BAFF-R and CD40.
Sakurai D; Kanno Y; Hase H; Kojima H; Okumura K; Kobata T
Eur J Immunol; 2007 Jan; 37(1):110-8. PubMed ID: 17154264
[TBL] [Abstract][Full Text] [Related]
14. BAFF costimulation of Toll-like receptor-activated B-1 cells.
Ng LG; Ng CH; Woehl B; Sutherland AP; Huo J; Xu S; Mackay F; Lam KP
Eur J Immunol; 2006 Jul; 36(7):1837-46. PubMed ID: 16791880
[TBL] [Abstract][Full Text] [Related]
15. TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties.
Mackay F; Schneider P
Cytokine Growth Factor Rev; 2008; 19(3-4):263-76. PubMed ID: 18514565
[TBL] [Abstract][Full Text] [Related]
16. APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop.
Moreaux J; Sprynski AC; Dillon SR; Mahtouk K; Jourdan M; Ythier A; Moine P; Robert N; Jourdan E; Rossi JF; Klein B
Eur J Haematol; 2009 Aug; 83(2):119-29. PubMed ID: 19456850
[TBL] [Abstract][Full Text] [Related]
17. Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation.
Kim J; Gross JA; Dillon SR; Min JK; Elkon KB
Autoimmunity; 2011 Mar; 44(2):69-81. PubMed ID: 21250838
[TBL] [Abstract][Full Text] [Related]
18. The uncertain glory of APRIL.
Medema JP; Planelles-Carazo L; Hardenberg G; Hahne M
Cell Death Differ; 2003 Oct; 10(10):1121-5. PubMed ID: 14502235
[TBL] [Abstract][Full Text] [Related]
19. APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity.
Yu G; Boone T; Delaney J; Hawkins N; Kelley M; Ramakrishnan M; McCabe S; Qiu WR; Kornuc M; Xia XZ; Guo J; Stolina M; Boyle WJ; Sarosi I; Hsu H; Senaldi G; Theill LE
Nat Immunol; 2000 Sep; 1(3):252-6. PubMed ID: 10973284
[TBL] [Abstract][Full Text] [Related]
20. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
Lee JJ; Ozcan E; Rauter I; Geha RS
Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
